Shareholders Equity (Quarterly) Chart

View Shareholders Equity (Quarterly) for VVTM.V.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shareholders Equity (Quarterly) Chart
Start Trial

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2005. Start Trial.
Date Value
March 31, 2026 -3.26M
December 31, 2025 -2.495M
September 30, 2025 -0.8014M
June 30, 2025 -1.23M
March 31, 2025 -1.153M
December 31, 2024 -1.115M
September 30, 2024 -1.071M
June 30, 2024 -1.03M
March 31, 2024 -0.993M
December 31, 2023 -0.957M
September 30, 2023 -0.902M
June 30, 2023 -0.842M
March 31, 2023 -0.805M
December 31, 2022 -0.773M
September 30, 2022 -0.752M
June 30, 2022 -0.719M
March 31, 2022 -0.678M
December 31, 2021 -0.635M
September 30, 2021 -0.588M
June 30, 2021 -0.53M
March 31, 2021 -0.474M
December 31, 2020 -0.392M
September 30, 2020 -3.921M
June 30, 2020 -3.983M
March 31, 2020 -8.444M
Date Value
December 31, 2019 -6.768M
September 30, 2019 -4.652M
June 30, 2019 -3.841M
March 31, 2019 -6.409M
December 31, 2018 -8.183M
September 30, 2018 -0.291M
June 30, 2018 0.573M
March 31, 2018 1.365M
December 31, 2017 2.094M
September 30, 2017 1.809M
June 30, 2017 1.602M
March 31, 2017 -0.148M
December 31, 2016 1.546M
September 30, 2016 3.543M
June 30, 2016 4.02M
March 31, 2016 3.881M
December 31, 2015 6.568M
September 30, 2015 9.726M
June 30, 2015 10.23M
March 31, 2015 10.56M
December 31, 2014 10.38M
September 30, 2014 12.97M
June 30, 2014 9.847M
March 31, 2014 8.509M
December 31, 2013 9.099M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
MedMira, Inc. -24.52M
MedX Health Corp. -10.70M
VentriPoint Diagnostics Ltd. -4.117M
Theralase Technologies, Inc. 1.950M
Profound Medical Corp. 70.67M

Shareholders Equity (Quarterly) Related Metrics